Peer Review reports
From: Challenges associated with the integration of immuno-oncology agents in clinical practice
| Original Submission | ||
|---|---|---|
| 22 Oct 2021 | Submitted | Original manuscript |
| 19 Dec 2021 | Reviewed | Reviewer Report |
| 3 Feb 2022 | Reviewed | Reviewer Report |
| 18 Feb 2022 | Reviewed | Reviewer Report |
| 23 May 2022 | Author responded | Author comments - Patrice Lazure |
| 3 Jun 2022 | Reviewed | Reviewer Report |
| 25 Jun 2022 | Reviewed | Reviewer Report |
| 28 Jun 2022 | Reviewed | Reviewer Report |
| 24 Aug 2022 | Author responded | Author comments - Patrice Lazure |
| Resubmission - Version 2 | ||
| 23 May 2022 | Submitted | Manuscript version 2 |
| 23 Oct 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Publishing | ||
| 31 Oct 2022 | Editorially accepted | |
| 12 Nov 2022 | Article published | 10.1186/s12909-022-03847-0 |
You can find further information about peer review here.